Abbott on March 11 announced the formation of the Abbott Pandemic Defense Coalition, a first-of-its-kind global scientific and public health partnership dedicated to the early detection of, and rapid response to, future pandemic threats.

Laboratory testing found that Regeneron Pharmaceuticals Inc.’s Covid-19 antibody cocktail can combat a coronavirus variant first found in South Africa, but a similar drug from Eli Lilly and Co. is inactive against it, according to a study.

The U.S. Food and Drug Administration gave Emergency Use Authorization (EUA) to a Covid-19 test developed by Roche that measures antibodies within the blood.

Qiagen readies launch of rapid COVID-19 antigen test (Reuters) – German diagnostic test maker Qiagen on Tuesday said it planned to launch a COVID-19 antigen test that can provide results […]

Antibody levels against the novel coronavirus rose and then held steady for up to four months in more than 90% of recovered Covid-19 patients in Iceland, according to a published study.

Researchers are developing simpler Covid-19 diagnostic tests for use outside of labs in an effort to make mass testing available, fast and inexpensive.

The National Institutes of Health is investing $248.7 million in seven diagnostic companies with new testing technologies to increase their testing capacities and make millions of rapid Covid-19 tests per week available by fall.

The Consistent Testing Terminology Working Group published a white paper with industry-wide recommendations for precision medicine testing terms to be utilized in patient education and communication.

In a BioSpace interview, Sorrento Therapeutics executives emphasized the stringent process the company went through in identifying the antibody STI-1499, which demonstrated 100 percent inhibition of SARS-CoV-2 in laboratory tests.

In the company’s daily blog about the precautions being taken to ensure continued service to the world, Amazon intends to build testing facilities for employees.